#43: NewsBot: ALKS News Alkermes Submits Marketing Authorization Application for Vivitrol(R) in the United Kingdom and Germany
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced... |
April 2, 2007
08:00:00 AM |
#42: NewsBot: ALKS News Zacks Analyst Interview Highlights: Alkermes, Johnson & Johnson, Cephalon and Eli Lilly.
CHICAGO--(BUSINESS WIRE)--Zacks.com releases the latest Analyst Interview.... |
March 13, 2007
03:00:00 AM |
#41: NewsBot: ALKS News Cowen and Co. Annual Health Care Conference to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) announced today... |
March 8, 2007
01:30:00 PM |
#40: NewsBot: ALKS News Alkermes Completes Patient Enrollment for Phase 1/2 Study of ALKS 29 for the Treatment of Alcohol Dependence
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced... |
March 6, 2007
05:00:00 AM |
#39: NewsBot: ALKS News Alkermes Announces Senior Management Succession Plan
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced... |
March 5, 2007
04:00:00 AM |
#38: NewsBot: ALKS News Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
CAMBRIDGE, Mass. & INDIANAPOLIS--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS)... |
January 8, 2007
05:01:00 AM |
#37: NewsBot: ALKS News Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
CAMBRIDGE, Mass. & LEXINGTON, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq:... |
January 4, 2007
05:00:00 AM |
#36: NewsBot: ALKS News JPMorgan Annual Healthcare Conference to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) announced today... |
January 2, 2007
01:00:00 PM |
#35: NewsBot: ALKS News Alkermes Announces Submission of New Drug Application for RISPERDAL(R) CONSTA(R) in Japan
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced... |
December 20, 2006
09:00:00 AM |
#34: NewsBot: ALKS News The NASDAQ Investor Program to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) announced today... |
December 4, 2006
01:51:00 PM |
#33: NewsBot: ALKS News Alkermes Announces Positive Data from Exploratory Study of Extended-Release Naltrexone for Blockade of Opioid Effect
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes (Nasdaq: ALKS) today announced... |
December 4, 2006
08:52:00 AM |
#32: NewsBot: ALKS News Lazard Capital Markets Life Sciences Conference to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) announced today... |
November 20, 2006
01:49:00 PM |
#31: NewsBot: ALKS News Piper Jaffray Health Care Conference to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) announced today... |
November 20, 2006
01:48:00 PM |
#30: NewsBot: ALKS News Alkermes Announces Second Quarter Fiscal 2007 Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced... |
November 2, 2006
01:00:00 PM |
#29: NewsBot: ALKS News CIBC World Markets Healthcare Conference to Webcast Alkermes' Corporate Presentation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) announced today... |
November 1, 2006
01:30:00 PM |
| 
| 
| 
| 
| 
| 
